Salicylate for the treatment of Kawasaki disease in children

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2006, Pages

  Baumer, J Harry ^a   Love, S J L ^b   Gupta, A ^b   Haines, L C ^b   Maconochie, I ^b   Dua, J S ^b  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; PLACEBO; SALICYLIC ACID;

CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; DATA ANALYSIS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG FEVER; DRUG MEGADOSE; EMBASE; EXTERNAL VALIDITY; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INFORMATION PROCESSING; INTERNAL VALIDITY; LOW DRUG DOSE; MEDLINE; METHODOLOGY; MONOTHERAPY; MUCOCUTANEOUS LYMPH NODE SYNDROME; OUTCOME ASSESSMENT; REVIEW; TREATMENT DURATION;

EID: 42749104282     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004175.pub2     Document Type: Review

References (61)

1. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shuomiya K, Hayashidera T, et al. Intravenous gamma-globulin for Kawasaki disease. Acta Paediatrica Japonica 1991;33(6):799-804.
2. Akagi T, Kato H, Inoue O, Sato N. Salicylate treatment in Kawasaki disease: high dose or low dose?. European Journal of Pediatrics 1991;150(9):642-6.
3. Barron KS, Murphy DJ Jr, Silverman ED, Ruttenberg HD, Wright GB, Franklin W, et al. Treatment of Kawaski syndrome: a comparison of two dosage regimens of intravenously administered immune globulin. Journal of Pediatrics 1990;117(4):638-44.
4. Bavdekar SB, Vaswani LK, Shalini H, Chandu KV, Gaikwad R, Kamat JR. Kawasaki disease. Journal of the Indian Medical Association 1998;96(8):257-8.
5. Bourrillon A, Seban E, Vitoux-Brot C. Kawasaki Syndrome [Le Syndrome de Kawasaki]. Presse Medicale 1989;18(18):933-6.
6. Carriere JP, Chaix Y, Grouteau E. Anti-iinflammatory treatment in Kawasaki disease. Medecine et Maladies Infectieuses 1998;28(Spec. Issue. July):581-5.
7. Corregan JJ Jr. Kawasaki disease and the plight of the platelet. American Journal of Diseases in Childhood 1986;140(12):1223-4.
8. Denning DW. Kawasaki disease and aspirin [Letter]. Lancet 1983;2(8350):621.
9. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995;96(6):1057- 61.
10. Falcini F, Cimaz R, Calabri GB, Picco P, Martini G, Marazzi MG, et al. Kawasaki's disease in northern Italy: a multicentre retrospective study of 250 patients. Clinical & Experimental Rheumatology 2002;20(3):421- 6.
11. Gersony WM. Predicting coronary aneurysms in Kawasaki disease [comment]. American Journal of Cardiology 1998;81(9):1162-4.
12. Glode MP, Joffe LS, Wiggins J Jr, Clarke SH, Hathaway WE. Effects of intravenous immune globulin on the coagulopathy of Kawasaki syndrome. Journal of Pediatrics 1989;115(3):469-73.
13. Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatrica Japonica 1991;33(6):805-10.
14. Hicks RV, Melish ME. Kawasaki syndrome: Rheumatic complaints and analysis of salicyate therapy. Arthritis & Rheumatism 1979;22(6):621.
15. Hsu CH, Chan MR, Hwang FY, Kao HA, Hung HY, Hsu CH. Efficacy of plasmin-treated intravenous gamma-globulin for therapy of Kawasaki syndrome. Pediatric Infectious Disease Journal 1993;12(6):509-12.
16. Hwang BT, Lin CY, Hsieh KS, Tsuei DH, Meng GC. High-dose intravenous gamma-globulin therapy in Kawasaki disease. Chung-Hua Min Kuo Hsiao Erh Ko i Hseuh Hui Tsa Chih 1989;30(1):15-22.
17. Hwang KP, Wu JR, Huang LY, Liou CC, Huang TY. Clinical manifestations and effects of IVGG in patients with Kawasaki Disease. Kaoshiung Journal of Medical Sciences 1996;12(3):159-66.
18. Ichida F, Fatica NS, Engle MA, O'Loughlin JE, Klein AA, Synder MS, et al. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin. Pediatrics 1987;80(6):828-35.
19. Jacobs JC. Successful treatment of Kawasaki Disease with high dose aspirin. Pediatric Research 1978;12:494.
20. Kato H, Koike S, Yokoyama T. Kawasaki disease: effect of treatment of coronary artery involvement. Pediatrics 1979;63(2):175-9.
21. Kato H, Koike S, Yokoyama T. Guideline for the treatment of cardiovascular sequelae in Kawasaki disease. Acta Paediatrica Japonica 1987;29(1):109-14.
22. Koren G, Rose V, Lavi S, Rowe R. Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease. JAMA 1985;254(6):767-9.
23. Koren G, Lavi S, Rose V, Rowe R. Kawasaki disease: review of the risk factors for coronary aneurysms. Journal of Pediatrics 1986;108(3):388-92.
24. Koren G, Silverman E, Sundel R, Edney P, Newburger JW, Klein J, et al. Decreased protein binding of salicylates in Kawasaki disease. Journal of Pediatrics 1991;118(3):456-9.
25. Koren G, Schaffer F, Silverman E, Walker S, Duffy C, Stein L, et al. Determinants of low serum concentrations of salicylates in patients with kawasaki disease. Journal of Pediatrics 1998;112(4):663-7.
26. Kusakawa S, Tatara K. Efficacies and risks of aspirin in the treatment of Kawasaki disease. Progress in Clinical & Biological Research 1987;250:401-13.
27. Laupland KB, Dele Davies H. Epidemiology, etiology and management of Kawasaki disease: state of the art. Pediatric Cardiology 1999;20(3):177-83.
28. Lee JH, Hung HY, Huang FY. Kawasaki disease with Reye syndrome: report of one case. Chung-Hua Min Kuo Hsiao Erh Ko i Hseuh Hui Tsa Chih 1992;33(1):67-71.
29. Lux KM. New hope for children with Kawasaki disease. Journal of Pediatric Nursing 1991;6(3):159-65.
30. Mason WH, Takahashi M. Kawasaki syndrome. Clinical Infectious Diseases 1999;28(2):169-85.
31. Matsubara T, Mason W, Kashani IA, Kligerman M, Burns JC. Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki Disesae. Journal of Pediatrics 1996;128(5 Pt 1):701-3.
32. Melish ME. Kawasaki syndrome. Annual Review of Medicine 1982;33:569-85.
33. Melish ME. Kawasaki syndrome (the mucocutaneous lymph node syndrome). Pediatric Annals 1982;11(2):255-68.
34. Melish ME, Takahashi M, Shulman ST, Reddy DV, Mason WH, Elise Duffy C, et al. Comparison of low dose aspirin (LDA) vs. high dose aspirin (HDA) as an adjunct to intravenous gamma globulin (IVIG) in the treatment of Kawasaki disease. Pediatric Research 1992;31:170A.
35. Nakashima L, Edwards DL. Treatment of Kawasaki disease. Clinical Pharmacy 1990;9(10):755-62.
36. Newburger JW. Treatment of Kawasaki disease. Lancet 1996;347(9009):1128.
37. Okada M, Satoh T, Hayashi T. Effect of intravenous gamma-globulin on neutrophil function in Kawasaki disease. Acta Paediatrica Japonica 1991;33(6):785-90.
38. Onouchi Z, Kawasaki T. Overview of pharmocological treatment of Kawasaki disease. Drugs 1999;58(5):813-22.
39. Pahl E. Cardiology for general pediatricians. Pediatric Annals 1997;26(2):129-31.
40. Rowley AH, Shulman ST. Kawasaki syndrome. Clinical Microbiology Review 1998;11(3):405-14.
41. Saphyakhajon P, Greene GR. Do we need high-dose acetylsalicylic acid in Kawasaki disease?. Journal of Pediatrics 1998;133(1):167.
42. Sato N, Sugimura T, Akagi T, Yamakawa R, Hashino K, Eto G, et al. Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness. Pediatrics International 1999;41(1):1-7.
43. Sundel RP, Newburger JW. Management of acute Kawasaki disease. Progress in Pediatric Cardiology 1997;6(3):203-9.
44. Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. Journal of Pediatrics 1997;131(6):888-93.
45. Tizard EJ. Recognition and management of Kawasaki disease. Current Paediatrics 1999;9(2):97-101.
46. Curtis N, Zheng R, Lamb JR. Evidence for a superantigen mediated process in Kawasaki disease. Archives of Disease in Childhood 1995;72(4):308-11.
47. Curtis N. Kawasaki Disease. BMJ 1997;315(7104):322-3.
48. Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87(5):1776-80.
49. Dhillon R, Newton L, Rudd PT, Hall SM. Management of Kawasaki disease in the British Isles. Archives of Diseases in Children 1993;69(6): 631-8.
50. Harnden A, Alves B, Sheikh A. Rising incidence in Kawasaki disease in England: analysis of hospital admission data. BMJ 2002;324(7351): 1424-5.
51. Kato H, Akagi T, Sugimura T, Sato N, Kazue T, Hashino K, et al. Kawasaki disease. Coronary Artery Disease 1995;6(3):194-206.
52. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involement with specific desquamation of the fingers and toes in children. Japanese Journal of Allergy 1967;16(3):178-222.
53. Leung DY, Messmer HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993;342(8884):1385-8.
54. Leung DY, Giorno RC, Kazemi LV, Flynn PA, Busse JB. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. Journal of Immunology 1995;155(10):5018-21.
55. Liu H, Zhou T, Wang X. Steroid hormone treatment for Kawasaki disease in children (Protocol for a Cochrane Review). In: The Cochrane Library, 4, 2001. Oxford: Update Software.
56. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959;22(4):719-48.
57. Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children (Cochrane Review). In: The Cochrane Library, 4, 2003. Oxford: Update Software.
58. Rowley AH, Gonzalez -Crussi F, Gidding SS, Duffy CE, Shulman ST. Incomplete Kawasaki disease with coronary artery involvement. Journal of Pediatrics 1987;110(3):409-13.
59. Royle JA, Williams K, Elliot E, Sholler G, Nolan T, Allen R, et al. Kawasaki disease in Australia,1993-1995. Archives of Disease in Childhood 1998;78(1):33-9.
60. Witt MT, Minich LL, Bohnsack JF, Young PC. Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria. Pediatrics 1997;104(1):e10.
61. Yanagawa H, Nakamura Y, Yashiro M, Oki I, Hirata S, Zhang T, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001;107(3):E33.